The bill, titled H.B. No. 1103, aims to enhance measures for preventing and responding to opioid-related drug overdoses at public institutions of higher education in Texas. It introduces a new subchapter, Subchapter Y-2, to Chapter 51 of the Education Code, which mandates that each institution adopt a policy ensuring the availability of opioid antagonists in residence halls. This includes provisions for the acquisition, maintenance, storage, administration, and disposal of these devices, as well as training for resident advisors on their proper use. The bill also requires that resident advisors be authorized and trained to administer opioid antagonists to individuals believed to be experiencing an overdose.

Additionally, the bill outlines the responsibilities of institutions regarding reporting the administration of opioid antagonists, training requirements for resident advisors, and the prescription process for opioid antagonists by physicians. It provides immunity from civil or criminal liability for individuals acting in good faith under the provisions of this subchapter, including those who administer opioid antagonists or report emergencies. Institutions are required to implement these measures by the fall semester of 2026, and the bill will take effect immediately if it receives a two-thirds vote from both houses of the legislature; otherwise, it will take effect on September 1, 2025.

Statutes affected:
Introduced: ()